Hoekema and Bergstein on the board
MIMETAS appoints André Hoekema and Bart Bergstein as members of the board
MIMETAS welcomes André Hoekema and Bart Bergstein as members of the board. Dr. Hoekema is Senior Vice President Corporate Development of Galapagos since March 2005. He joined Galapagos from Invitrogen Corporation, where he was Managing Director of Corporate Development Europe. He brings 20 years of biotech experience from positions at Molecular Probes Europe (Managing Director), Crucell (Director of Business Development), DSM Life Sciences and MOGEN (Research and Project Management) and Genentech, Inc (R&D). Bart Bergstein is one of the founders of Forbion Capital Partners. He has 15 years of experience in venture capital and has broad transactional and management experience. Bart serves currently on the board of several life sciences companies. Bart holds a masters degree in construction engineering from the Technical University of Eindhoven. Herbert Heyneker will continue in to serve in his position as the chairman of the board of MIMETAS.